期刊文献+

Characteristics of gastric cancer in peptic ulcer patients with Helicobacter pylori infection 被引量:15

Characteristics of gastric cancer in peptic ulcer patients with Helicobacter pylori infection
下载PDF
导出
摘要 AIM:To evaluate the incidence and clinical characteristics of gastric cancer(GC) in peptic ulcer patients with Helicobacter pylori(H.pylori) infection.METHODS:Between January 2003 and December 2013, the medical records of patients diagnosed with GC were retrospectively reviewed.Those with previous gastric ulcer(GU) and H.pylori infection were assigned to the Hp GU-GC group(n = 86) and those with previous duodenal ulcer(DU) disease and H.pylori infection were assigned to the Hp DUGC group(n = 35).The incidence rates of GC in the Hp GU-GC and Hp DU-GC groups were analyzed.Data on demographics(age, gender, peptic ulcer complications and cancer treatment), GC clinical characteristics [location, pathological diagnosis, differentiation, T stage, Lauren's classification, atrophy of surrounding mucosa and intestinal metaplasia(IM)], outcome of eradication therapy for H.pylori infection, esophagogastroduodenoscopy number and the duration until GC onset were reviewed.Univariate and multivariate analyses were performed to identify factors influencing GC development.The relative risk of GC was evaluated using a Cox proportional hazards model.RESULTS:The incidence rates of GC were 3.60%(86/2387) in the Hp GU-GC group and 1.66%(35/2098) in the Hp DU-GC group.The annual incidence was 0.41% in the Hp GU-GC group and 0.11% in the Hp DUGC group.The rates of moderate-to-severe atrophy of the surrounding mucosa and IM were higher in the Hp GU-GC group than in the Hp DU-GC group(86% vs 34.3%, respectively, and 61.6% vs 14.3%, respectively, P < 0.05).In the univariate analysis, atrophy of surrounding mucosa, IM and eradication therapy for H.pylori infection were significantly associated with the development of GC(P < 0.05).There was no significant difference in the prognosis of GC patients between the Hp GU-GC and Hp DU-GC groups(P = 0.347).The relative risk of GC development in the Hp GUGC group compared to that of the Hp DU-GC group,after correction for age and gender,was 1.71(95%CI:1.09-2.70;P=0.02).CONCLUSION:GU patients with H.pylori infection had higher GC incidence rates and relative risks.Atrophy of surrounding mucosa,IM and eradication therapy were associated with GC. AIM:To evaluate the incidence and clinical characteristics of gastric cancer(GC) in peptic ulcer patients with Helicobacter pylori(H.pylori) infection.METHODS:Between January 2003 and December 2013, the medical records of patients diagnosed with GC were retrospectively reviewed.Those with previous gastric ulcer(GU) and H.pylori infection were assigned to the Hp GU-GC group(n = 86) and those with previous duodenal ulcer(DU) disease and H.pylori infection were assigned to the Hp DUGC group(n = 35).The incidence rates of GC in the Hp GU-GC and Hp DU-GC groups were analyzed.Data on demographics(age, gender, peptic ulcer complications and cancer treatment), GC clinical characteristics [location, pathological diagnosis, differentiation, T stage, Lauren's classification, atrophy of surrounding mucosa and intestinal metaplasia(IM)], outcome of eradication therapy for H.pylori infection, esophagogastroduodenoscopy number and the duration until GC onset were reviewed.Univariate and multivariate analyses were performed to identify factors influencing GC development.The relative risk of GC was evaluated using a Cox proportional hazards model.RESULTS:The incidence rates of GC were 3.60%(86/2387) in the Hp GU-GC group and 1.66%(35/2098) in the Hp DU-GC group.The annual incidence was 0.41% in the Hp GU-GC group and 0.11% in the Hp DUGC group.The rates of moderate-to-severe atrophy of the surrounding mucosa and IM were higher in the Hp GU-GC group than in the Hp DU-GC group(86% vs 34.3%, respectively, and 61.6% vs 14.3%, respectively, P < 0.05).In the univariate analysis, atrophy of surrounding mucosa, IM and eradication therapy for H.pylori infection were significantly associated with the development of GC(P < 0.05).There was no significant difference in the prognosis of GC patients between the Hp GU-GC and Hp DU-GC groups(P = 0.347).The relative risk of GC development in the Hp GUGC group compared to that of the Hp DU-GC group,after correction for age and gender,was 1.71(95%CI:1.09-2.70;P=0.02).CONCLUSION:GU patients with H.pylori infection had higher GC incidence rates and relative risks.Atrophy of surrounding mucosa,IM and eradication therapy were associated with GC.
出处 《World Journal of Gastroenterology》 SCIE CAS 2015年第16期4954-4960,共7页 世界胃肠病学杂志(英文版)
关键词 GASTRIC cancer GASTRIC ULCER Duodenalulcer HELICOBACTER PYLORI ERADICATION therapy Gastric cancer Gastric ulcer Duodenal ulcer Helicobacter pylori Eradication therapy
  • 相关文献

参考文献35

  • 1McColl KE. Clinical practice. Helicobacter pylori infection.N Engl J Med 2010; 362: 1597-1604 [PMID: 20427808 DOI:10.1056/NEJMcp1001110].
  • 2Parsonnet J, Friedman GD, Vandersteen DP, Chang Y, VogelmanJH, Orentreich N, Sibley RK. Helicobacter pylori infection andthe risk of gastric carcinoma. N Engl J Med 1991; 325: 1127-1131[PMID: 1891020 DOI: 10.1056/NEJM199110173251603].
  • 3Stewart BW, Kleihues P. World cancer report. Lyon: IARC Press,2003: 194.
  • 4Parsonnet J, Harris RA, Hack HM, Owens DK. Modelling costeffectivenessof Helicobacter pylori screening to prevent gastriccancer: a mandate for clinical trials. Lancet 1996; 348: 150-154[PMID: 8684154 DOI: 10.1016/S0140-6736(96)01501-2].
  • 5Hopkins RJ, Girardi LS, Turney EA. Relationship betweenHelicobacter pylori eradication and reduced duodenal and gastriculcer recurrence: a review. Gastroenterology 1996; 110: 1244-1252[PMID: 8613015 DOI: 10.1053/gast.1996.v110.pm8613015].
  • 6Rosenstock S, Jgensen T, Bonnevie O, Andersen L. Risk factorsfor peptic ulcer disease: a population based prospective cohortstudy comprising 2416 Danish adults. Gut 2003; 52: 186-193[PMID: 12524398 DOI: 10.1136/gut.52.2.186].
  • 7Hansson LE, Nyr O, Hsing AW, Bergstr R, JosefssonS, Chow WH, Fraumeni JF, Adami HO. The risk of stomachcancer in patients with gastric or duodenal ulcer disease. N EnglJ Med 1996; 335: 242-249 [PMID: 8657240 DOI: 10.1056/NEJM199607253350404].
  • 8Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S,Yamakido M, Taniyama K, Sasaki N, Schlemper RJ. Helicobacterpylori infection and the development of gastric cancer. N EnglJ Med 2001; 345: 784-789 [PMID: 11556297 DOI: 10.1056/NEJMoa001999].
  • 9Molloy RM, Sonnenberg A. Relation between gastric cancer andprevious peptic ulcer disease. Gut 1997; 40: 247-252 [PMID:9071940 DOI: 10.1136/gut.40.2.247].
  • 10Take S, Mizuno M, Ishiki K, Nagahara Y, Yoshida T, YokotaK, Oguma K, Okada H, Shiratori Y. The effect of eradicatinghelicobacter pylori on the development of gastric cancer in patientswith peptic ulcer disease. Am J Gastroenterol 2005; 100: 1037-1042[PMID: 15842576 DOI: 10.1111/j.1572-0241.2005.41384.x].

同被引文献131

引证文献15

二级引证文献130

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部